Thermo Fisher to acquire PPD for $17.4B

By The Science Advisory Board staff writers

April 15, 2021 -- Thermo Fisher Scientific announced it will acquire clinical research services company PPD for a total cash purchase price of $17.4 billion plus the assumption of approximately $3.5 billion of net debt.

PPD has more than 26,000 colleagues operating in nearly 50 countries. In 2020, the company generated revenue of $4.7 billion. Upon close of the transaction, PPD will become part of Thermo Fisher's Laboratory Products and Services Segment.

The transaction is expected to be completed by the end of 2021, subject to the satisfaction of customary closing conditions, including the receipt of applicable regulatory approvals.

Thermo Fisher debuts KingFisher Apex sample purification system
Thermo Fisher Scientific launched its new KingFisher Apex Purification System, a high-throughput sample purification instrument designed to automate the...
Thermo Fisher optimizes mass spec software, launches new Gibco media
Thermo Fisher Scientific announced that it plans to collaborate with Protein Metrics on mass spectrometry data analysis for biopharmaceutical and proteomics...
Thermo Fisher to spend $600M to up bioprocessing production
Thermo Fisher Scientific plans to invest up to $600 million to expand its bioprocessing production capabilities through 2022.

Copyright © 2021 scienceboard.net


Conferences
Microscopy and Microanalysis Meeting
July 31 - August 4
Portland, Oregon United States
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter